Skip to main content
Future Medicine Co., Ltd. logo

Future Medicine Co., Ltd. — Investor Relations & Filings

Ticker · 341170 ISIN · KR7341170009 KO Manufacturing
Open in API
Filings indexed 93 across all filing types
Latest filing 2024-12-16 Regulatory Filings
Country KR South Korea
Listing KO 341170

About Future Medicine Co., Ltd.

http://futuremedicine.co.kr/

Future Medicine Co., Ltd. is a new drug development company specializing in nucleoside-based synthetic drugs. The company focuses on creating therapeutics for diseases with high unmet medical needs, particularly in antiviral and anticancer applications. Its primary pipeline candidate, FM101, is an anti-inflammatory and anti-fibrotic agent being investigated for the treatment of conditions such as non-alcoholic steatohepatitis (NASH), diabetic nephropathy, and primary biliary cholangitis (PBC). The company has also conducted research and filed patents for therapeutics related to coronaviruses.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory notice regarding the setting of a record date and shareholder register closure period for an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal regulatory notification of the meeting preparation. Given the nature of the announcement regarding shareholder rights and meeting preparation, it fits best under the general regulatory filing category.
2024-12-16 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is explicitly marked as a '정정신고' (Correction Report). It details changes to previously granted stock options, including the number of recipients and the total number of shares involved. This type of disclosure regarding stock option grants and their subsequent amendments falls under the category of regulatory filings related to capital structure and share-based compensation, which is best classified as a Regulatory Filing (RNS) as it does not fit into specific categories like Director's Dealing or Share Issue.
2024-12-06 Korean
기업설명회(IR)개최결과
Regulatory Filings Classification · 1% confidence The document is a short, structured announcement reporting the results of an Investor Relations (IR) meeting held by Future Medicine. It lists the date, time, location, attendees, and agenda items of the meeting. It does not contain the actual presentation slides or detailed financial analysis, but rather serves as a formal notification that the event occurred and where the materials can be found. According to the 'Menu vs Meal' rule, this is an announcement of an event/report rather than the report itself, fitting the criteria for a Regulatory Filing (RNS) or a general announcement.
2024-11-29 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, time, location, target audience, and purpose of the meeting. Since this is an announcement of an event rather than the presentation materials themselves, and it does not fit into specific categories like earnings releases or financial reports, it is classified as a Regulatory Filing (RNS) as it serves as a standard corporate disclosure notice.
2024-11-21 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 1% confidence The document is a regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically functions as a '정정신고' (Correction Report) regarding previously granted stock options. It details changes in the number of recipients and the total number of shares granted due to employee departures. This type of disclosure regarding stock option grants and their subsequent adjustments is a standard regulatory requirement for listed companies, falling under the category of general regulatory filings.
2024-07-19 Korean
기업설명회(IR)개최결과
Regulatory Filings Classification · 1% confidence The document is a short, structured announcement detailing the results of an Investor Relations (IR) meeting held by Future Medicine. It lists the date, location, participants, and agenda items of the meeting, and provides a link to where the actual IR materials are posted. Since it is a brief notification regarding the occurrence of an event and the availability of materials rather than the presentation itself, it falls under the category of a regulatory filing announcement.
2024-06-25 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.